Clinical Trial Update: A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of ITI-1284 for agitation associated with Alzheimer's dementia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ITI-1284

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Agitation Associated With Alzheimer's Dementia | Phase 2 | Status: RECRUITING